These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 8458108

  • 1. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW, Zeitler R, Fitzpatrick P.
    Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
    [Abstract] [Full Text] [Related]

  • 2. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
    Lancet; 1992 Mar 28; 339(8796):753-70. PubMed ID: 1347801
    [Abstract] [Full Text] [Related]

  • 3. TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis.
    Barbagelata NA, Granger CB, Oqueli E, Suárez LD, Borruel M, Topol EJ, Califf RM.
    Am Heart J; 1997 Mar 28; 133(3):273-82. PubMed ID: 9060794
    [Abstract] [Full Text] [Related]

  • 4. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL, Rothbard RL, Hackworthy RA, Sorensen SG, Fitzpatrick PG, Dahl CF, Hagan AD, Browne KF, Symkoviak GP, Menlove RL.
    J Am Coll Cardiol; 1988 Jun 28; 11(6):1153-63. PubMed ID: 3284943
    [Abstract] [Full Text] [Related]

  • 5. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD.
    J Am Coll Cardiol; 1994 Dec 28; 24(7):1602-10. PubMed ID: 7963104
    [Abstract] [Full Text] [Related]

  • 6. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Dec 28; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 7. Thrombolytic therapy in acute myocardial infarction.
    Rutherford JD, Braunwald E.
    Chest; 1990 Apr 28; 97(4 Suppl):136S-145S. PubMed ID: 2108851
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: the Duke University Clinical Cardiology Study (DUCCS) 1.
    O'Connor CM, Meese R, Carney R, Smith J, Conn E, Burks J, Hartman C, Roark S, Shadoff N, Heard M.
    J Am Coll Cardiol; 1994 Jan 28; 23(1):11-8. PubMed ID: 8277068
    [Abstract] [Full Text] [Related]

  • 9. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov 28; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 10. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
    Lancet; 1990 Jul 14; 336(8707):65-71. PubMed ID: 1975321
    [Abstract] [Full Text] [Related]

  • 11. Current issues concerning thrombolytic therapy for acute myocardial infarction.
    Hennekens CH, O'Donnell CJ, Ridker PM, Marder VJ.
    J Am Coll Cardiol; 1995 Jun 14; 25(7 Suppl):18S-22S. PubMed ID: 7775709
    [Abstract] [Full Text] [Related]

  • 12. Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.
    Held PH, Teo KK, Yusuf S.
    Circulation; 1990 Nov 14; 82(5):1668-74. PubMed ID: 2146038
    [Abstract] [Full Text] [Related]

  • 13. Thrombolytic, antiplatelet, and antithrombotic agents.
    Grines CL.
    Am J Cardiol; 1992 Dec 21; 70(21):18I-26I. PubMed ID: 1471601
    [Abstract] [Full Text] [Related]

  • 14. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS).
    Neuhaus KL, von Essen R, Tebbe U, Vogt A, Roth M, Riess M, Niederer W, Forycki F, Wirtzfeld A, Maeurer W.
    J Am Coll Cardiol; 1992 Apr 21; 19(5):885-91. PubMed ID: 1552106
    [Abstract] [Full Text] [Related]

  • 15. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators.
    N Engl J Med; 1993 Sep 02; 329(10):673-82. PubMed ID: 8204123
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
    Baxter-Jones CS, White HD, Anderson JL.
    J Interv Cardiol; 1993 Mar 02; 6(1):15-23. PubMed ID: 10171637
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study.
    Bassand JP, Cassagnes J, Machecourt J, Lusson JR, Anguenot T, Wolf JE, Maublant J, Bertrand B, Schiele F.
    Circulation; 1991 Sep 02; 84(3):1107-17. PubMed ID: 1909218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.